DE60329126D1 - Konjugate mit biologisch abbaubarem polymer und verwendung dafür - Google Patents
Konjugate mit biologisch abbaubarem polymer und verwendung dafürInfo
- Publication number
- DE60329126D1 DE60329126D1 DE60329126T DE60329126T DE60329126D1 DE 60329126 D1 DE60329126 D1 DE 60329126D1 DE 60329126 T DE60329126 T DE 60329126T DE 60329126 T DE60329126 T DE 60329126T DE 60329126 D1 DE60329126 D1 DE 60329126D1
- Authority
- DE
- Germany
- Prior art keywords
- conjugates
- polymer
- biodegradable polymer
- apyrase
- biologically active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L59/00—Compositions of polyacetals; Compositions of derivatives of polyacetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35830302P | 2002-02-20 | 2002-02-20 | |
| PCT/US2003/004845 WO2003070823A2 (en) | 2002-02-20 | 2003-02-19 | Conjugates comprising a biodegradable polymer and uses therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60329126D1 true DE60329126D1 (de) | 2009-10-15 |
Family
ID=27757725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60329126T Expired - Lifetime DE60329126D1 (de) | 2002-02-20 | 2003-02-19 | Konjugate mit biologisch abbaubarem polymer und verwendung dafür |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7785618B2 (de) |
| EP (2) | EP2138575B8 (de) |
| AT (1) | ATE441706T1 (de) |
| AU (1) | AU2003219796A1 (de) |
| DE (1) | DE60329126D1 (de) |
| WO (1) | WO2003070823A2 (de) |
Families Citing this family (89)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8106098B2 (en) * | 1999-08-09 | 2012-01-31 | The General Hospital Corporation | Protein conjugates with a water-soluble biocompatible, biodegradable polymer |
| US20060177416A1 (en) | 2003-10-14 | 2006-08-10 | Medivas, Llc | Polymer particle delivery compositions and methods of use |
| US7723296B2 (en) | 2001-01-18 | 2010-05-25 | Genzyme Corporation | Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof |
| ATE410459T1 (de) | 2002-01-14 | 2008-10-15 | Gen Hospital Corp | Bioabbaubare polyketale, verfahren zu ihrer herstellung sowie ihre verwendung |
| AU2003219796A1 (en) * | 2002-02-20 | 2003-09-09 | Beth Israel Deaconess Medical Center | Conjugates comprising a biodegradable polymer and uses therefor |
| JP4800614B2 (ja) * | 2002-07-19 | 2011-10-26 | ザ ジェネラル ホスピタル コーポレイション | オキシム結合体、およびそれらの形成および使用のための方法 |
| CA2537993C (en) | 2003-09-05 | 2012-08-28 | The General Hospital Corporation | Dual phase drug release system |
| EP1877099B1 (de) * | 2005-04-06 | 2012-09-19 | Genzyme Corporation | Therapeutische konjugate beinhaltend ein lysosomales enzym, polysialinsäure und eine zielkomponente |
| WO2007038246A2 (en) | 2005-09-22 | 2007-04-05 | Medivas, Llc | Solid polymer delivery compositions and methods for use thereof |
| EP1926780B1 (de) | 2005-09-22 | 2013-08-14 | Medivas, LLC | Bis-( -amino)-diol-diester-haltige poly(esteramid) und poly(esterurethan)-zusammensetzungen und verwendungsverfahren |
| DE102006046411A1 (de) * | 2006-09-20 | 2008-03-27 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Arzneimittel zur Prophylaxe oder Behandlung oder Diagnostik von akutem Lungenversagen (ALI) |
| KR101273813B1 (ko) * | 2006-10-04 | 2013-06-11 | 메드라드, 인크. | 중재 카테터 |
| EP2089438B1 (de) * | 2006-11-07 | 2010-03-03 | DSM IP Assets B.V. | Carbamat, thiocarbamat oder carbamid mit einer biomolekularen gruppierung |
| HUE036140T2 (hu) | 2007-01-18 | 2018-06-28 | Genzyme Corp | Aminooxi-csoportot tartalmazó oligoszacharidok és ezek konjugátjai |
| WO2008104200A1 (en) * | 2007-03-01 | 2008-09-04 | Gelato Corporation N.V. | Use of apyrase for the treatment of a pathology resulting from endotoxin activity |
| US8202528B2 (en) * | 2007-06-05 | 2012-06-19 | Abbott Cardiovascular Systems Inc. | Implantable medical devices with elastomeric block copolymer coatings |
| CA2700441A1 (en) | 2007-09-24 | 2009-04-02 | Noxxon Pharma Ag | C5a binding nucleic acids |
| BRPI0820229A2 (pt) * | 2007-11-28 | 2017-05-09 | A Stevenson Cheri | conjugados de análogos de fumagilina biodegradáveis biocompatíveis |
| WO2009111615A2 (en) | 2008-03-05 | 2009-09-11 | Thrombovision, Inc. | Systems for measuring properties of a physiological fluid suspension |
| US20090292042A1 (en) * | 2008-05-21 | 2009-11-26 | Patterson Greg S | Biodegradable material and plant container |
| CA2833960C (en) | 2008-09-22 | 2015-12-22 | Tyrx, Inc. | Linear polyesteramides from aminophenolic esters |
| US8491880B2 (en) * | 2008-12-10 | 2013-07-23 | Mersana Therapeutics, Inc. | Pharmaceutical formulations of biodegradable biocompatible camptothecin-polymer conjugates |
| BRPI0923047B8 (pt) | 2008-12-16 | 2021-05-25 | Genzyme Corp | métodos para preparação de conjugados de proteínas- oligossacarídeos |
| US20120065254A1 (en) | 2009-03-23 | 2012-03-15 | Noxxon Pharma Ag | C5A binding nucleic acids and the use thereof |
| US9839628B2 (en) | 2009-06-01 | 2017-12-12 | Tyrx, Inc. | Compositions and methods for preventing sternal wound infections |
| ITAN20100002A1 (it) * | 2010-01-25 | 2011-07-26 | Biolog S R L | Materiale polimerico sintentico biodegradabile |
| EP2553019A1 (de) | 2010-03-26 | 2013-02-06 | Mersana Therapeutics, Inc. | Modifizierte polymere zur freisetzung von polynukleotiden, verfahren zu ihrer herstellung und verfahren zu ihrer verwendung |
| EP2561079A1 (de) | 2010-04-21 | 2013-02-27 | Noxxon Pharma AG | Lipidbindende nukleinsäuren |
| KR101210713B1 (ko) * | 2010-06-29 | 2012-12-10 | 가톨릭대학교 산학협력단 | 온도 민감성 생리활성 물질 전달체 및 이의 제조방법 |
| EP2605650A4 (de) | 2010-08-18 | 2014-05-21 | Del Mar Pharmaceuticals | Zusammensetzungen und verfahren zur erhöhung des therapeutischen nutzens suboptimal verabreichter chemischer verbindungen einschliesslich substituierter hexitole wie dianhydrogalactitol und diacetyldianhydrogalactitol |
| WO2012025251A1 (en) | 2010-08-27 | 2012-03-01 | Noxxon Pharma Ag | Nucleic acids for treatment of chronic complications of diabetes |
| SG188220A1 (en) | 2010-09-09 | 2013-04-30 | Noxxon Pharma Ag | Sdf-1 binding nucleic acids and the use thereof in cancer treatment |
| JP2014503187A (ja) | 2010-10-29 | 2014-02-13 | ノクソン ファーマ エージー | 身体からヘプシジンを除去するためのヘプシジン結合核酸の使用 |
| WO2012095303A1 (en) | 2011-01-10 | 2012-07-19 | Noxxon Pharma Ag | Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same |
| US8815226B2 (en) | 2011-06-10 | 2014-08-26 | Mersana Therapeutics, Inc. | Protein-polymer-drug conjugates |
| AU2012267447B2 (en) * | 2011-06-10 | 2016-10-20 | Mersana Therapeutics, Inc. | Protein-polymer-drug conjugates |
| US9873765B2 (en) | 2011-06-23 | 2018-01-23 | Dsm Ip Assets, B.V. | Biodegradable polyesteramide copolymers for drug delivery |
| CA2839526A1 (en) | 2011-06-23 | 2012-12-27 | Dsm Ip Assets B.V. | Micro- or nanoparticles comprising a biodegradable polyesteramide copolymer for use in the delivery of bioactive agents |
| WO2014081405A2 (en) | 2011-08-17 | 2014-05-30 | Dennis Brown | Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dibromodulcitol |
| AU2012325233A1 (en) | 2011-10-21 | 2014-04-24 | Noxxon Pharma Ag | Glucagon binding nucleic acids |
| US9518265B2 (en) | 2012-01-10 | 2016-12-13 | Noxxon Pharma Ag | C5a binding nucleic acids |
| SG11201403769YA (en) | 2012-01-10 | 2014-07-30 | Noxxon Pharma Ag | Nucleic acids specifically binding cgrp |
| CN110711188A (zh) | 2012-01-20 | 2020-01-21 | 德玛公司 | 经取代的己糖醇类用于治疗恶性肿瘤的用途 |
| CA2868302A1 (en) | 2012-03-23 | 2013-09-26 | Dennis M. Brown | Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo |
| WO2013169600A1 (en) | 2012-05-09 | 2013-11-14 | Delmar Pharmaceuticals | Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignancies |
| MX367055B (es) | 2012-06-26 | 2019-08-02 | Del Mar Pharmaceuticals | El uso de una composición que comprende dianhidrogalactitol, diacetildianhidrogalactitol, y dibromodulcitol, y análogos o derivados de cada uno para el tratamiento de malignidades resistentes a inhibidores de tirosina cinasa. |
| WO2014026078A1 (en) * | 2012-08-10 | 2014-02-13 | Rutgers, The State University Of New Jersey Asb Iii | Attenuating or treating sepsis or septic shock |
| US11491154B2 (en) | 2013-04-08 | 2022-11-08 | Dennis M. Brown | Therapeutic benefit of suboptimally administered chemical compounds |
| RU2015148055A (ru) * | 2013-04-11 | 2017-05-16 | Вандербилт Юниверсити | Полиплексы |
| KR20160104612A (ko) | 2013-07-26 | 2016-09-05 | 업데이트 파마 인코포레이트 | 비산트렌의 치료 효과 개선용 조성물 |
| JP6747971B2 (ja) | 2013-10-15 | 2020-08-26 | シアトル ジェネティックス， インコーポレイテッド | 改善されたリガンド−薬物コンジュゲート薬物動態のためのｐｅｇ化薬物−リンカー |
| WO2015062743A1 (en) | 2013-11-04 | 2015-05-07 | Noxxon Pharma Ag | Means and methods for the treatment of nephropathy |
| WO2015154064A2 (en) | 2014-04-04 | 2015-10-08 | Del Mar Pharmaceuticals | Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer |
| US10293044B2 (en) | 2014-04-18 | 2019-05-21 | Auburn University | Particulate formulations for improving feed conversion rate in a subject |
| US20150297706A1 (en) | 2014-04-18 | 2015-10-22 | Auburn University | Particulate Vaccine Formulations for Inducing Innate and Adaptive Immunity |
| US10434071B2 (en) | 2014-12-18 | 2019-10-08 | Dsm Ip Assets, B.V. | Drug delivery system for delivery of acid sensitivity drugs |
| MX2018006218A (es) | 2015-12-04 | 2018-09-05 | Seattle Genetics Inc | Conjugados de compuestos de tubulisina cuaternizada. |
| US11793880B2 (en) | 2015-12-04 | 2023-10-24 | Seagen Inc. | Conjugates of quaternized tubulysin compounds |
| GB201522541D0 (en) * | 2015-12-21 | 2016-02-03 | Inst Research In Biomedicine | Compositions |
| US10973792B2 (en) | 2019-02-13 | 2021-04-13 | Axcess Global Sciences, Llc | Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use |
| US11103470B2 (en) | 2017-11-22 | 2021-08-31 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
| US10596130B2 (en) | 2017-12-19 | 2020-03-24 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use |
| US11185518B2 (en) | 2017-12-19 | 2021-11-30 | Axcess Global Sciences, Llc | S-beta-hydroxybutyrate compounds and compositions enriched with S-enantiomer |
| US11241403B2 (en) | 2016-03-11 | 2022-02-08 | Axcess Global Sciences, Llc | Beta-hydroxybutyrate mixed salt compositions and methods of use |
| US10736861B2 (en) | 2016-03-11 | 2020-08-11 | Axcess Global Sciences, Llc | Mixed salt compositions for producing elevated and sustained ketosis |
| US10596129B2 (en) | 2017-11-22 | 2020-03-24 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
| US10245242B1 (en) | 2017-11-22 | 2019-04-02 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
| US10973786B2 (en) | 2016-03-11 | 2021-04-13 | Axcess Global Sciences, Llc | R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, and RS-beta-hydroxybutyrate mixed salt compositions |
| US10245243B1 (en) | 2017-12-19 | 2019-04-02 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use |
| US10596131B2 (en) | 2017-11-22 | 2020-03-24 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
| EA201892040A1 (ru) | 2016-03-25 | 2019-04-30 | Сиэтл Дженетикс, Инк. | Способ получения пегилированных соединений лекарственный препарат - линкер и их промежуточных соединений |
| EP3443095A1 (de) | 2016-04-15 | 2019-02-20 | Noxxon Pharma AG | Verfahren zur modulation der anzahl und der verteilung von tumorinfiltrierenden leukozyten bei tumoren |
| US10583199B2 (en) | 2016-04-26 | 2020-03-10 | Northwestern University | Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs |
| JP2020512312A (ja) | 2017-03-24 | 2020-04-23 | シアトル ジェネティックス， インコーポレイテッド | グルクロニド薬物−リンカーの調製のためのプロセスおよびその中間体 |
| US11202769B2 (en) | 2017-11-22 | 2021-12-21 | Axcess Global Sciences, Llc | Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function |
| US10925843B2 (en) * | 2018-04-18 | 2021-02-23 | Axcess Global Sciences, Llc | Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate |
| US11944598B2 (en) | 2017-12-19 | 2024-04-02 | Axcess Global Sciences, Llc | Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer |
| US10512615B1 (en) | 2018-08-27 | 2019-12-24 | Axcess Global Sciences, Llc | Compositions and methods for delivering cannabidiol and ketone bodies |
| US11806324B2 (en) | 2018-04-18 | 2023-11-07 | Axcess Global Sciences, Llc | Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies |
| US11419836B2 (en) | 2019-02-13 | 2022-08-23 | Axcess Global Sciences, Llc | Racemic and near racemic beta-hydroxybutyrate mixed salt-acid compositions |
| US11129802B2 (en) | 2018-08-27 | 2021-09-28 | Axcess Global Sciences, Llc | Compositions and methods for delivering cannabidiol and ketone bodies |
| US11241401B2 (en) | 2020-02-06 | 2022-02-08 | Axcess Global Sciences, Llc | Enantiomerically pure r-beta-hydroxybutyrate mixed salt-acid compositions |
| US10980772B2 (en) | 2018-08-27 | 2021-04-20 | Axcess Global Sciences, Llc | Compositions and methods for delivering tetrahydrocannabinol and ketone bodies |
| CN109303923B (zh) * | 2018-11-09 | 2021-05-11 | 东南大学 | 一种制备类羟基磷灰石成分的纳米簇凝胶的方法 |
| CN113660930A (zh) * | 2019-02-11 | 2021-11-16 | 阿克塞斯全球科学有限责任公司 | β-羟基丁酸盐混合盐-酸组合物和使用方法 |
| US11950616B2 (en) | 2019-06-21 | 2024-04-09 | Axcess Global Sciences, Llc | Non-vasoconstricting energy-promoting compositions containing ketone bodies |
| US11033553B2 (en) | 2019-06-21 | 2021-06-15 | Axcess Global Sciences, Llc | Non-vasoconstricting energy-promoting compositions containing ketone bodies |
| EP4306640A1 (de) | 2022-06-21 | 2024-01-17 | TME Pharma AG | Verfahren zur behandlung eines tumors in einem patienten |
| WO2023247651A1 (en) | 2022-06-21 | 2023-12-28 | TME Pharma AG | Methods for treating a tumor in a subject |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES437153A1 (es) * | 1974-05-06 | 1977-04-16 | Marburgnlahn | Procedimiento para la preparacion de un compuesto biologica-mente activo a base de poli(hidroximetileno) o poli(carbona-to de vinileno). |
| SU761477A1 (ru) * | 1978-07-10 | 1980-09-07 | Datse Yu Baltsere | Способ получения водорастворимого препарата целлюлазы . . 1 |
| US4215051A (en) | 1979-08-29 | 1980-07-29 | Standard Oil Company (Indiana) | Formation, purification and recovery of phthalic anhydride |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4766072A (en) | 1985-07-17 | 1988-08-23 | Promega Corporation | Vectors for in vitro production of RNA copies of either strand of a cloned DNA sequence |
| US4729956A (en) * | 1986-05-01 | 1988-03-08 | Phillips Petroleum Company | Stabilized alcohol oxidase compositions and method for producing same |
| US4843147A (en) * | 1986-11-06 | 1989-06-27 | University Of British Columbia | Anhydrous enhanced coupling of proteins |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| GB8826429D0 (en) * | 1988-11-11 | 1988-12-14 | Univ Leeds Ind Service Ltd | Enzyme stabilisation systems |
| US5198346A (en) | 1989-01-06 | 1993-03-30 | Protein Engineering Corp. | Generation and selection of novel DNA-binding proteins and polypeptides |
| US5096815A (en) | 1989-01-06 | 1992-03-17 | Protein Engineering Corporation | Generation and selection of novel dna-binding proteins and polypeptides |
| JPH03158758A (ja) * | 1989-11-17 | 1991-07-08 | Tosoh Corp | デキストランを介して結合した二以上の物質の複合体及び該複合体の製造方法 |
| US5221495A (en) * | 1990-04-13 | 1993-06-22 | Colgate-Palmolive Company | Enzyme stabilizing composition and stabilized enzyme containing built detergent compositions |
| NZ237570A (en) * | 1990-04-13 | 1993-09-27 | Colgate Palmolive Co | Enzyme stabilising composition and stabilised enzyme-containing built detergent compositions |
| EP0606217B2 (de) | 1991-06-27 | 2008-12-03 | Bristol-Myers Squibb Company | CTL4A Rezeptor, ihn enthaltenden Fusionsproteine und deren Verwendungen |
| ZA933926B (en) * | 1992-06-17 | 1994-01-03 | Amgen Inc | Polyoxymethylene-oxyethylene copolymers in conjuction with blomolecules |
| AU4778893A (en) | 1992-07-21 | 1994-02-14 | General Hospital Corporation, The | System of drug delivery to the lymphatic tissues |
| US5378601A (en) | 1992-07-24 | 1995-01-03 | Montefiore Medical Center | Method of preserving platelets with apyrase and an antioxidant |
| US5399665A (en) | 1992-11-05 | 1995-03-21 | Massachusetts Institute Of Technology | Biodegradable polymers for cell transplantation |
| US5279565A (en) | 1993-02-03 | 1994-01-18 | Localmed, Inc. | Intravascular treatment apparatus and method |
| JP3158758B2 (ja) * | 1993-02-19 | 2001-04-23 | 松下電器産業株式会社 | 端末アダプタ装置とデータ伝送方法 |
| US6179817B1 (en) | 1995-02-22 | 2001-01-30 | Boston Scientific Corporation | Hybrid coating for medical devices |
| CA2216445A1 (en) | 1995-03-24 | 1996-10-03 | Novartis Ag | Gene therapy for transplantation and inflammatory or thrombotic conditions |
| US5811510A (en) | 1995-04-14 | 1998-09-22 | General Hospital Corporation | Biodegradable polyacetal polymers and methods for their formation and use |
| WO1996040792A1 (en) * | 1995-06-07 | 1996-12-19 | Novo Nordisk A/S | Modification of polypeptides |
| US6312921B1 (en) | 1996-07-26 | 2001-11-06 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
| US6248327B1 (en) | 1998-09-11 | 2001-06-19 | Vanderbilt University | Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis |
| WO2000023459A1 (en) | 1998-10-16 | 2000-04-27 | Immunex Corporation | Inhibitors of platelet activation and recruitment |
| US6822086B1 (en) | 1999-08-09 | 2004-11-23 | The General Hospital Corporation | Drug-carrier complexes and methods of use thereof |
| US7160924B2 (en) | 2002-07-19 | 2007-01-09 | The General Hospital Corporation | Protein conjugates with a water-soluble biocompatible, biodegradable polymer |
| ATE410459T1 (de) * | 2002-01-14 | 2008-10-15 | Gen Hospital Corp | Bioabbaubare polyketale, verfahren zu ihrer herstellung sowie ihre verwendung |
| AU2003219796A1 (en) * | 2002-02-20 | 2003-09-09 | Beth Israel Deaconess Medical Center | Conjugates comprising a biodegradable polymer and uses therefor |
| US20040205840A1 (en) * | 2003-04-11 | 2004-10-14 | Pioneer Hi-Bred International, Inc. | Method for reducing gene expression |
-
2003
- 2003-02-19 AU AU2003219796A patent/AU2003219796A1/en not_active Abandoned
- 2003-02-19 EP EP09011078.4A patent/EP2138575B8/de not_active Expired - Lifetime
- 2003-02-19 AT AT03716070T patent/ATE441706T1/de not_active IP Right Cessation
- 2003-02-19 WO PCT/US2003/004845 patent/WO2003070823A2/en not_active Application Discontinuation
- 2003-02-19 EP EP03716070A patent/EP1585817B1/de not_active Expired - Lifetime
- 2003-02-19 DE DE60329126T patent/DE60329126D1/de not_active Expired - Lifetime
-
2004
- 2004-08-20 US US10/922,378 patent/US7785618B2/en not_active Expired - Fee Related
-
2010
- 2010-08-27 US US12/870,030 patent/US20110044967A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003070823A2 (en) | 2003-08-28 |
| EP2138575B1 (de) | 2013-06-19 |
| EP2138575A1 (de) | 2009-12-30 |
| US20110044967A1 (en) | 2011-02-24 |
| ATE441706T1 (de) | 2009-09-15 |
| AU2003219796A1 (en) | 2003-09-09 |
| AU2003219796A8 (en) | 2003-09-09 |
| US7785618B2 (en) | 2010-08-31 |
| EP1585817B1 (de) | 2009-09-02 |
| EP1585817A2 (de) | 2005-10-19 |
| WO2003070823A3 (en) | 2004-08-26 |
| EP2138575B8 (de) | 2013-07-24 |
| EP1585817A4 (de) | 2005-12-28 |
| WO2003070823A9 (en) | 2005-06-02 |
| US20050169968A1 (en) | 2005-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60329126D1 (de) | Konjugate mit biologisch abbaubarem polymer und verwendung dafür | |
| EP1196444B8 (de) | Exendin-4 konjugate und ihre medizinische verwendung | |
| DE69910216D1 (de) | Konjugate zur behandlung von entzündungskrankheiten und von assozierter gewebeschädigung | |
| ATE263579T1 (de) | Abgabe von polyethylene glycol-molekül- konjugaten aus abbaubarem hydrogel | |
| ATE296116T1 (de) | Ein kovalentes konjugat von clozapine und einer fettsäure und dessen verwendung zur behandlung von schizophrenie | |
| CY1109458T1 (el) | Ιστικο μοσχευμα | |
| CY1110505T1 (el) | Ανθρωπινα αντισωματα dr4 και χρησεις αυτων | |
| BR0100084A (pt) | Lagarta de borracha sem-fim e veìculo contendo tal lagarta | |
| CY1109151T1 (el) | Αντισωματα dr4 και χρησεις αυτων | |
| BR0308090A (pt) | conjugados de agentes citotóxicos ou terapêuticos e peptìdios biologicamente ativos | |
| MXPA03010085A (es) | Composiciones y su uso en la hiperplasia. | |
| TR200101867T2 (tr) | CCR5 modülatörleri olarak piperidinler | |
| ATE336255T1 (de) | Hyaluronsäure-ester zur behandlung von normotrophischen hautnarben | |
| ATE444086T1 (de) | Therapeutische zusammensetzungen und verfahren zur behandlung von periodontitis mit entzündunshemmenden mitteln | |
| DE60143065D1 (de) | Bildgebende Verfahren, Diagnose und Behandlung von Krankheiten | |
| BR0007666A (pt) | Composição cosmética com base em mentol e mentil lactato, tendo pouco odor e sendo não irritante | |
| DE60140864D1 (de) | Therapeutische zusammenfassungen und verfahren zur modulierung von v3, eine isoform von versican | |
| PT1150716E (pt) | Composicao farmaceutica de proteinas hedgehog hidrofobicamente modificadas e sua utilizacao | |
| WO2000050023A8 (en) | Use of tamoxifen and related compounds as clc3 blockers in the treatment of vascular diseases | |
| DE59706692D1 (de) | Konjugat, geeignet zur bindung von substanzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |